Segra is an agriculture technology company offering innovative services that accelerate the advancement of the cannabis industry to better serve society. The company’s plant tissue culture and genomics technologies, coupled with a vast business ecosystem, empower its clients to drive financial performance and mitigate risk, while exploring the next frontiers of optimized cultivation practices for the rapidly evolving medical, recreational, and hemp markets. Segra is developing industrial-scale facilities to produce disease-free, robust, and DNA fingerprinted cannabis plantlets for licensed producers globally. To support this vision, Segra has assembled a world-class team of specialists in the fields of agronomy, molecular genetics, plant tissue culture, and regulatory compliance. Segra currently has agreements with many leading global cannabis producers, including the Canadian licensed producers HEXO Corp., Agripharm Corp., and The Supreme Cannabis Company Inc.
Read more about Segra
Jerry Kieran | Executive Chairman@Segra
After a wonderful journey at Fluence Bioengineering, culminating with the acquisition by Osram to position them for global expansion, I have the pleasure to continue supporting the growth of the cannabis industry and accelerating its convergence with traditional commercial agriculture. The journey continues with exploring the tremendous financial gains for large scale cannabis producers to begin production with proprietary and exclusive tissue-cultured genetics that are ‘fingerprinted’ and pathogen-free as they embrace the journey of discovery for enhanced chemotype expression within optimized cultivation conditions. With many partners, including Catalyst and Segra, we look forward to serving our clients, the evolving consumer, and the medical community as we collaboratively uncover the benefits this plant can offer society. It’s truly an incredible time to be serving the commercial agriculture and healthcare industries!